Does the Gadoxetic Acid-Enhanced Liver MRI Impact on the Treatment of Patients with Colorectal Cancer? Comparison Study with <sup>18</sup>F-FDG PET/CT

<div>A 51-year-old woman with sigmoid colon cancer, who showed liver metastasis only on Gadoxetic acid-enhanced liver MRI. (a) Axial <sup>18</sup>F-FDG-PET/CT image shows inhomogeneous physiologic activity of liver but no definite metastatic nodule. (b) Axial image of hepatocyte-phase on liver MRI shows a focal signal defect in segment 2 suggesting metastatic nodule (arrow).</div>

BioMed Research International

fig3

Figure 3

Figure 3: Does the Gadoxetic Acid-Enhanced Liver MRI Impact on the Treatment of Patients with Colorectal Cancer? Comparison Study with <sup>18</sup>F-FDG PET/CT 

Figure 3 | Does the Gadoxetic Acid-Enhanced Liver MRI Impact on the Treatment of Patients with Colorectal Cancer? Comparison Study with 18F-FDG PET/CT 